lncRNA HCG11 suppresses cell proliferation in hormone receptor-positive breast cancer via SRSF1/β-catenin

Hormone receptor positive (HR-positive) breast cancer (BC) is the most common subtype of breast cancer. Despite adjuvant endocrine therapy and chemotherapy-based treatment, the therapeutic response is often not satisfactory in HR-positive BC patients. Therefore, elucidating the mechanisms that regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Dan, Li, Saiyang, Wang, Xuehui, Fang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876628/
https://www.ncbi.nlm.nih.gov/pubmed/36602530
http://dx.doi.org/10.18632/aging.204468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876628/
https://www.ncbi.nlm.nih.gov/pubmed/36602530
http://dx.doi.org/10.18632/aging.204468

Ejemplares similares